February 18, 2021

Funding Opportunities: Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards for sequencing-based surveillance studies of the SARS-CoV-2 virus to track variants circulating in communities the IDeA and NARCH programs serve. The supplements will support SARS-CoV-2 viral genome sequencing and analysis studies. Projects are expected to expand on or collaborate with ongoing SARS-CoV-2 testing studies or programs in order to leverage resources and deliver results quickly to help address the urgent challenge.

Applications are due by March 31, 2021; see NOT-GM-21-031 for additional details.

If you have any questions about this supplement opportunity, please contact me.


About the Author

Hongwei Gao

Hongwei Gao

Hongwei’s scientific expertise is focused on pathoimmunology. He manages multicomponent grants supported through the Institutional Development Award (IDeA) program.